Ignite Creation Date:
2024-05-06 @ 7:39 AM
Last Modification Date:
2024-10-26 @ 11:50 AM
Study NCT ID:
NCT02573220
Status:
WITHDRAWN
Last Update Posted:
2016-12-09
First Post:
2015-09-21
Brief Title:
Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal Cancer
Sponsor:
University of Chicago
Organization:
University of Chicago
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IVB Colorectal Cancer |
| Stage IVA Colorectal Cancer |
Keywords: